457 related articles for article (PubMed ID: 26266975)
1. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours.
Koren S; Reavie L; Couto JP; De Silva D; Stadler MB; Roloff T; Britschgi A; Eichlisberger T; Kohler H; Aina O; Cardiff RD; Bentires-Alj M
Nature; 2015 Sep; 525(7567):114-8. PubMed ID: 26266975
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.
Van Keymeulen A; Lee MY; Ousset M; Brohée S; Rorive S; Giraddi RR; Wuidart A; Bouvencourt G; Dubois C; Salmon I; Sotiriou C; Phillips WA; Blanpain C
Nature; 2015 Sep; 525(7567):119-23. PubMed ID: 26266985
[TBL] [Abstract][Full Text] [Related]
3. Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors.
Meyer DS; Brinkhaus H; Müller U; Müller M; Cardiff RD; Bentires-Alj M
Cancer Res; 2011 Jul; 71(13):4344-51. PubMed ID: 21482677
[TBL] [Abstract][Full Text] [Related]
4. Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors.
Tikoo A; Roh V; Montgomery KG; Ivetac I; Waring P; Pelzer R; Hare L; Shackleton M; Humbert P; Phillips WA
PLoS One; 2012; 7(5):e36924. PubMed ID: 22666336
[TBL] [Abstract][Full Text] [Related]
5. Luminal progenitors restrict their lineage potential during mammary gland development.
Rodilla V; Dasti A; Huyghe M; Lafkas D; Laurent C; Reyal F; Fre S
PLoS Biol; 2015 Feb; 13(2):e1002069. PubMed ID: 25688859
[TBL] [Abstract][Full Text] [Related]
6. Lineage-Restricted Mammary Stem Cells Sustain the Development, Homeostasis, and Regeneration of the Estrogen Receptor Positive Lineage.
Van Keymeulen A; Fioramonti M; Centonze A; Bouvencourt G; Achouri Y; Blanpain C
Cell Rep; 2017 Aug; 20(7):1525-1532. PubMed ID: 28813665
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling.
Cheng H; Liu P; Ohlson C; Xu E; Symonds L; Isabella A; Muller WJ; Lin NU; Krop IE; Roberts TM; Winer EP; Arteaga CL; Zhao JJ
Oncogene; 2016 Jun; 35(23):2961-70. PubMed ID: 26640141
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
Wang A; Arantes S; Yan L; Kiguchi K; McArthur MJ; Sahin A; Thames HD; Aldaz CM; Macleod MC
BMC Cancer; 2008 Sep; 8():268. PubMed ID: 18808719
[TBL] [Abstract][Full Text] [Related]
9. Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation.
Liu JC; Wang DY; Egan SE; Zacksenhaus E
Oncotarget; 2016 Feb; 7(8):9060-8. PubMed ID: 26814435
[TBL] [Abstract][Full Text] [Related]
10. Initiating breast cancer by PIK3CA mutation.
Miller TW
Breast Cancer Res; 2012 Feb; 14(1):301. PubMed ID: 22315990
[TBL] [Abstract][Full Text] [Related]
11. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
Adams JR; Xu K; Liu JC; Agamez NM; Loch AJ; Wong RG; Wang W; Wright KL; Lane TF; Zacksenhaus E; Egan SE
Cancer Res; 2011 Apr; 71(7):2706-17. PubMed ID: 21324922
[TBL] [Abstract][Full Text] [Related]
13. PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews.
Xia HJ; He BL; Wang CY; Zhang HL; Ge GZ; Zhang YX; Lv LB; Jiao JL; Chen C
Eur J Cancer; 2014 Dec; 50(18):3230-42. PubMed ID: 25457635
[TBL] [Abstract][Full Text] [Related]
14. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
[TBL] [Abstract][Full Text] [Related]
16. Stem Cells and the Differentiation Hierarchy in Mammary Gland Development.
Fu NY; Nolan E; Lindeman GJ; Visvader JE
Physiol Rev; 2020 Apr; 100(2):489-523. PubMed ID: 31539305
[TBL] [Abstract][Full Text] [Related]
17. Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.
Blaas L; Pucci F; Messal HA; Andersson AB; Josue Ruiz E; Gerling M; Douagi I; Spencer-Dene B; Musch A; Mitter R; Bhaw L; Stone R; Bornhorst D; Sesay AK; Jonkers J; Stamp G; Malanchi I; Toftgård R; Behrens A
Nat Cell Biol; 2016 Dec; 18(12):1346-1356. PubMed ID: 27798604
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells.
Isakoff SJ; Engelman JA; Irie HY; Luo J; Brachmann SM; Pearline RV; Cantley LC; Brugge JS
Cancer Res; 2005 Dec; 65(23):10992-1000. PubMed ID: 16322248
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
